Corrigendum to “Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up”: [Annals of Oncology volume 31 (2020) 1476–1490, (S0923753420421076), (10.1016/j.annonc.2020.08.2099)]
Articolo
Data di Pubblicazione:
2022
Abstract:
The authors regret that the legend to Fig. 4 of this publication was given incorrectly. The correction is as follows: For “CVD, cyclophosphamide, vincristine, doxorubicin” read “CVD, cyclophosphamide, vincristine, dacarbazine”. The authors would like to apologise for any inconvenience caused.
Tipologia CRIS:
1.1 Articolo in rivista
Elenco autori:
Fassnacht, M.; Assie, G.; Baudin, E.; Eisenhofer, G.; Fouchardiere, C. D. L.; Haak, H. R.; de Krijger, R.; Porpiglia, F.; Terzolo, M.; Berruti, A.
Link alla scheda completa:
Pubblicato in: